Pulling SEC filings + quote and writing the call…

Microbot Medical Inc.
Next earnings Aug 10, 2026 · consensus $-0.09 EPS, $459K rev
Conservative balance sheet (liabilities/equity 0.05x); but revenue fell -88.5% YoY.
Microbot Medical Inc. shows $117K in FY2015 revenue (-88.5% YoY), a -11243.3% net margin, and -16.9% ROE.
Sources: SEC EDGAR (CIK 0000883975, latest 10-Q filed 2026-05-13) · as of 6/26/2026, 4:05:49 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$11.4M | -$13.3M | -$9.86M | -$11.6M | -$14.7M |
| Net income | -$11.3M | -$13.2M | -$10.7M | -$11.4M | -$13.1M |
| Diluted EPS | — | -$1.81 | -$1.05 | -$0.73 | -$0.29 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1047 tracked peers · median